Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHUK | O15111 | 2/20 | 0.56 |
| ▸ | DHODH | Q02127 | 1/20 | 0.51 |
| ▸ | ACMSD | Q8TDX5 | 3/20 | 0.48 |
| ▸ | HNF4A | P41235 | 2/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.48 |
| ▸ | DHFR | P00374 | 1/20 | 0.48 |
| ▸ | QDPR | P09417 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.48 |
| ▸ | CDC7 | O00311 | 2/20 | 0.47 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.47 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.47 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.46 |
| ▸ | CDK9 | P50750 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29436303 | 0.87 | KMT2A (0.60) | ACMSDHNF4AMCL1DHFRKDM4E | |
| SCHEMBL9550353 | 0.87 | KMT2A (0.60) | ACMSDHNF4AMCL1DHFRKDM4E | |
| SCHEMBL710222 | 0.87 | KMT2A (0.60) | ACMSDHNF4AMCL1DHFRKDM4E | |
| SCHEMBL30690398 | 0.85 | KMT2A (0.62) | ACMSDHNF4AMCL1DHFRKDM4E | |
| SCHEMBL30690397 | 0.85 | KMT2A (0.62) | ACMSDHNF4AMCL1DHFRKDM4E | |
| SCHEMBL33365 | 0.85 | KMT2A (0.62) | ACMSDHNF4AMCL1DHFRKDM4E | |
| SCHEMBL5544965 | 0.85 | HNF4A (0.70) | CHUKACMSDHNF4AMCL1DHFR | |
| SCHEMBL23421721 | 0.83 | RXRB (0.57) | CHUKDHODHACMSDHNF4AMCL1 | |
| SCHEMBL3104322 | 0.83 | XDH (0.57) | CHUKDHODHACMSDHNF4AQDPR | |
| SCHEMBL205528 | 0.83 | ROCK2 (0.55) | CHUKDHODHACMSDHNF4AQDPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121736310-A | Pb metal organic framework material with zeolite topology structure, preparation method and application | 西安工程大学 | 2026-03-27 | — | — | CN | disclosed |
| CN-116313541-A | Sulfur-modified copper/cuprous oxide electrode material and preparation method thereof | 北京化工大学 | 2023-06-23 | — | — | CN | disclosed |
| US-8076348-B2 | Acylguanidine derivative or salt thereof | ASTELLAS PHARMA INC. (JP) | 2011-12-13 | — | — | US | disclosed |
| EP-1923387-B1 | ACYLGUANIDINE DERIVATIVE OR SALT THEREOF | ASTELLAS PHARMA INC (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-20100168096-A1 | ACYLGUANIDINE DERIVATIVE OR SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2010-07-01 | — | — | US | disclosed |
| EP-1923387-A1 | ACYLGUANIDINE DERIVATIVE OR SALT THEREOF | Astellas Pharma Inc. (JP) | 2008-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168096-A1 | ACYLGUANIDINE DERIVATIVE OR SALT THEREOF | HTR2B, HTR7, HTR3B | CHUK 1036/4885DHODH 2882/4885ACMSD 441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.